BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9732103)

  • 1. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
    Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
    J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma].
    Niewczas M; Paczek L; Krawczyk M; Pawlak J; Bartłomiejczyk I; Górnicka B
    Pol Arch Med Wewn; 2002 Jul; 108(1):653-62. PubMed ID: 12412410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
    Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
    An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-2-antichymotrypsin in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kiluk S; Gluszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):817-23. PubMed ID: 2467852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic activity and serum protease inhibitors in nasal secretions from adult patients with common colds.
    Hamaguchi Y; Ohi M; Ukai K; Sakakura Y; Miyoshi Y
    Rhinology; 1986 Jun; 24(2):125-32. PubMed ID: 2943014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypsin, elastase, plasmin and MMP-9 activity in the serum during the human ageing process.
    Paczek L; Michalska W; Bartlomiejczyk I
    Age Ageing; 2008 May; 37(3):318-23. PubMed ID: 18332058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alkaline-stable acid thiol proteinase--a possible marker for primary liver carcinoma.
    Dufek V; Matous B; Král V
    Neoplasma; 1984; 31(1):99-107. PubMed ID: 6142423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
    Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
    Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of cathepsin D and alpha(1)-antitrypsin in the blood serum of patients with mammary carcinoma.
    Wozniak A; Mila-Kierzenkowska C; Schachtschabel DO; Wozniak B; Rozwodowska M; Drewa T; Drewa S; Sir J; Sir I; Maciak R; Krzyzynska-Malinowska E
    Exp Oncol; 2005 Sep; 27(3):233-7. PubMed ID: 16244588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
    Mero M; Tenhunen R; Pessi T; Sandholm M
    Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute-phase proteins in colorectal cancer].
    Dumitraşcu D; Stanciu L; Radu D; Dejica D; Ban A; Ioniţă A; Petcovici M; Duca S; Cazacu M; Funaru G
    Med Interna; 1992; 44(2-4):41-6. PubMed ID: 1285361
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in serum cathepsin B-like activity in patients with colorectal cancer.
    Dufek V; Jirásek V; Král V; Matous B; Drazná E
    Neoplasma; 1985; 32(1):51-4. PubMed ID: 3982561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D activity in colorectal cancer.
    Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
    Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of lysosomal and nonlysosomal proteases and contents of protein and its degradation products in the blood serum of rats with fibrosarcoma induced by methylcholanthrene.
    Gołaszewski Z; Pałka J; Sobolewski K; Ostrowska H; Gołaszewska J
    Rocz Akad Med Bialymst; 1997; 42(1):218-24. PubMed ID: 9581483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha 1-antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer].
    Dumitraşcu D; Radu D; Stanciu L; Ioniţă A; Petcovici M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):57-61. PubMed ID: 2479968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease.
    Pederson ED; Stanke SR; Whitener SJ; Sebastiani PT; Lamberts BL; Turner DW
    Arch Oral Biol; 1995 Dec; 40(12):1151-5. PubMed ID: 8850655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
    Geraghty P; Rogan MP; Greene CM; Brantly ML; O'Neill SJ; Taggart CC; McElvaney NG
    Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
    Fabris C; Del Favero G; Panucci A; Plebani M; Di Mario F; Piccoli A; Basso D; Burlina A; Naccarato R
    Enzyme; 1986; 35(2):82-6. PubMed ID: 2427333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum alpha-1 proteinase inhibitor in advanced cancer: mass variants and functionally inert forms.
    Chawla RK; Lawson DH; Sarma PR; Nixon DW; Travis J
    Cancer Res; 1987 Feb; 47(4):1179-84. PubMed ID: 3492270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.